Alcoholic Cardiomyopathy Diagnosis and Management
Diagnostic Considerations
- The clinical diagnosis of alcoholic cardiomyopathy can be made when biventricular dysfunction and dilation are persistently observed in a person with a significant history of alcohol use, in the absence of other known causes of myocardial disease, according to the American Heart Association 1.
- Alcoholic cardiomyopathy typically develops in men aged 30-55 years who have been heavy drinkers for more than 10 years, though patients consuming >90 grams of alcohol daily for >5 years are at risk, as stated by the American College of Cardiology 1.
- The presence of SVT and NSVT is consistent with alcoholic cardiomyopathy, as arrhythmias are common manifestations of alcohol-induced myocardial damage, according to the American College of Radiology 5, 6.
Management Priorities
- Total abstinence from alcohol is the cornerstone of treatment and the most critical intervention for reversing myocardial damage, as recommended by the American College of Cardiology 3, 2, 4.
- Complete abstinence is associated with improvement in depressed left ventricular function, with numerous reports documenting reversibility after cessation of drinking, according to the American Heart Association 3, 2.
- Without complete abstinence, the 4-year mortality for alcoholic cardiomyopathy approaches 50%, with mortality rates of 40-50% within 3-6 years for those who continue drinking, as stated by the American College of Cardiology 2, 4.
- Start standard heart failure therapy including ACE inhibitors or ARBs, beta-blockers, mineralocorticoid receptor antagonists, diuretics for volume management, and SGLT2 inhibitors, as recommended by the American College of Cardiology 3, 4.